Literature DB >> 25400870

Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis.

Antonio Facciorusso1, Matteo Antonino1, Marianna Di Maso1, Nicola Muscatiello1.   

Abstract

AIM: To compare endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for early gastric cancer (EGC).
METHODS: Computerized bibliographic search was performed on PubMed/Medline, Embase, Google Scholar and Cochrane library databases. Quality of each included study was assessed according to current Cochrane guidelines. Primary endpoints were en bloc resection rate and histologically complete resection rate. Secondary endpoints were length of procedure, post-treatment bleeding, post-procedural perforation and recurrence rate. Comparisons between the two treatment groups across all the included studies were performed by using Mantel-Haenszel test for fixed-effects models (in case of low heterogeneity) or DerSimonian and Laird test for random-effects models (in case of high heterogeneity).
RESULTS: Ten retrospective studies (8 full text and 2 abstracts) were included in the meta-analysis. Overall data on 4328 lesions, 1916 in the ESD and 2412 in the EMR group were pooled and analyzed. The mean operation time was longer for ESD than for EMR (standardized mean difference 1.73, 95%CI: 0.52-2.95, P = 0.005) and the "en bloc" and histological complete resection rates were significantly higher in the ESD group [OR = 9.69 (95%CI: 7.74-12.13), P < 0.001 and OR = 5.66, (95%CI: 2.92-10.96), P < 0.001, respectively]. As a consequence of its greater radicality, ESD provided lower recurrence rate [OR = 0.09, (95%CI: 0.05-0.17), P < 0.001]. Among complications, perforation rate was significantly higher after ESD [OR = 4.67, (95%CI, 2.77-7.87), P < 0.001] whereas the bleeding incidences did not differ between the two techniques [OR = 1.49 (0.6-3.71), P = 0.39].
CONCLUSION: In the endoscopic therapy of EGC, ESD showed a superior efficacy but higher complication rate with respect to EMR.

Entities:  

Keywords:  Early gastric cancer; Endoscopic mucosal resection; Endoscopic submucosal dissection; Meta-analysis

Year:  2014        PMID: 25400870      PMCID: PMC4231495          DOI: 10.4253/wjge.v6.i11.555

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  21 in total

1.  Gastric mucosal cancer smaller than 7mm can be treated with conventional endoscopic mucosal resection as effectively as with endoscopic submucosal dissection.

Authors:  Tatsuyuki Watanabe; Keiichiro Kume; Mayumi Taip; Michihiko Shibata; Hiroaki Kubo; Yutaka Ejiri; Makoto Otsuki
Journal:  Hepatogastroenterology       Date:  2010 May-Jun

2.  Advantages of endoscopic submucosal dissection over conventional endoscopic mucosal resection.

Authors:  Takaya Shimura; Makoto Sasaki; Hiromi Kataoka; Satoshi Tanida; Tadayuki Oshima; Naotaka Ogasawara; Tsuneya Wada; Eiji Kubota; Tomonori Yamada; Yoshinori Mori; Fumitaka Fujita; Haruhisa Nakao; Hirotaka Ohara; Masami Inukai; Kunio Kasugai; Takashi Joh
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

3.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models.

Authors:  J Robins; N Breslow; S Greenland
Journal:  Biometrics       Date:  1986-06       Impact factor: 2.571

6.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Authors:  Shiro Oka; Shinji Tanaka; Iwao Kaneko; Ritsuo Mouri; Mayuko Hirata; Toru Kawamura; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

7.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  A multicenter retrospective study of endoscopic resection for early gastric cancer.

Authors:  Ichiro Oda; Daizo Saito; Masahiro Tada; Hiroyasu Iishi; Satoshi Tanabe; Tsuneo Oyama; Toshihiko Doi; Yoshihide Otani; Junko Fujisaki; Yoichi Ajioka; Tsutomu Hamada; Haruhiro Inoue; Takuji Gotoda; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

9.  Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection.

Authors:  Kenichiro Watanabe; Shinichi Ogata; Seiji Kawazoe; Kazuyo Watanabe; Takanori Koyama; Tetsuro Kajiwara; Yuichiro Shimoda; Yukari Takase; Kouji Irie; Masanobu Mizuguchi; Seiji Tsunada; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  Gastrointest Endosc       Date:  2006-05       Impact factor: 9.427

10.  Benefits of endoscopic submucosal dissection according to size and location of gastric neoplasm, compared with conventional mucosal resection.

Authors:  Shu Hoteya; Toshiro Iizuka; Daisuke Kikuchi; Naohisa Yahagi
Journal:  J Gastroenterol Hepatol       Date:  2009-03-11       Impact factor: 4.029

View more
  41 in total

Review 1.  Comparison of endoscopic resection and gastrectomy for the treatment of early gastric cancer: a meta-analysis.

Authors:  Fan-Sheng Meng; Zhao-Hong Zhang; Ya-Mei Wang; Lin Lu; Jin-Zhou Zhu; Feng Ji
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

2.  Endoscopic submucosal dissection for early neoplastic lesions in the surgically altered stomach: a systematic review and meta-analysis.

Authors:  Mohamed Barakat; Mohamed Seif; Mohamed M Abdelfatah; Andrew Ofosu; David L Carr-Locke; Mohamed O Othman
Journal:  Surg Endosc       Date:  2019-04-08       Impact factor: 4.584

Review 3.  Updates on Management of Gastric Cancer.

Authors:  Fabian M Johnston; Michael Beckman
Journal:  Curr Oncol Rep       Date:  2019-06-24       Impact factor: 5.075

Review 4.  Heparin-Bridging Therapy and Risk of Bleeding After Endoscopic Submucosal Dissection for Gastric Neoplasms: a Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Tomoki Sempokuya; Karn Wijarnpreecha; Patompong Ungprasert
Journal:  J Gastrointest Cancer       Date:  2018-03

5.  Development and validation of a risk score for advanced colorectal adenoma recurrence after endoscopic resection.

Authors:  Antonio Facciorusso; Marianna Di Maso; Gaetano Serviddio; Gianluigi Vendemiale; Nicola Muscatiello
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

6.  Endoscopic submucosal dissection of gastric tumors: A systematic review and meta-analysis.

Authors:  Emmanuel Akintoye; Itegbemie Obaitan; Arunkumar Muthusamy; Olalekan Akanbi; Mayowa Olusunmade; Diane Levine
Journal:  World J Gastrointest Endosc       Date:  2016-08-10

7.  Endoscopic submucosal dissection of colorectal neoplasms: an audit of its safety and efficacy in a single tertiary centre in Singapore.

Authors:  James Weiquan Li; Tiing Leong Ang; Lai Mun Wang; Andrew Boon Eu Kwek; Malcolm Teck Kiang Tan; Kwong Ming Fock; Eng Kiong Teo
Journal:  Singapore Med J       Date:  2019-02-18       Impact factor: 1.858

Review 8.  Recent developments and innovations in gastric cancer.

Authors:  Mehmet Mihmanli; Enver Ilhan; Ufuk Oguz Idiz; Ali Alemdar; Uygar Demir
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

9.  Efficacy and safety of an internal magnet traction device for endoscopic submucosal dissection: ex vivo study in a porcine model (with video).

Authors:  Akira Dobashi; Andrew C Storm; Louis M Wong Kee Song; Christopher J Gostout; Jodie L Deters; Charles A Miller; Mary A Knipschield; Elizabeth Rajan
Journal:  Surg Endosc       Date:  2018-10-23       Impact factor: 4.584

Review 10.  Endoscopic or Surgical Resection for Gastro-Esophageal Cancer.

Authors:  Ines Gockel; Albrecht Hoffmeister
Journal:  Dtsch Arztebl Int       Date:  2018-08-06       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.